ChinaDaily Briefs

China: Alibaba Group, Sihuan Pharmaceutical Hldgs, Logan Property Holdings and more

In today’s briefing:

  • Alibaba (9988 HK) Pre-Earnings: Still Active Under Lockdown, Buy
  • Sihuan Pharmaceutical Hldgs (460.HK)- Privatization Rumor, Upside Potential and Concerns on Business
  • Morning Views Asia: Powerlong Commercial Management Holdings, SJM Holdings

Alibaba (9988 HK) Pre-Earnings: Still Active Under Lockdown, Buy

By Ming Lu

  • We estimate that the revenue growth will rise to 11.5% YoY in 4Q22 from 9.7% YoY in 3Q22.
  • Freshippo is the store chain closest to the operation before the lockdown among all large retailers.
  • We believe the stock has an upside of 27% for March 2023.

Sihuan Pharmaceutical Hldgs (460.HK)- Privatization Rumor, Upside Potential and Concerns on Business

By Xinyao (Criss) Wang

  • The reason why Sihuan has received more attention from the market mainly lies in the medical aesthetics segment. However, both hyaluronic acid and botulinum toxin are facing challenges.
  • Recently, China Resources is rumored to be in talks to privatize Sihuan Pharmaceutical Hldgs (460 HK), but Sihuan denied it.
  • Sihuan is undervalued. The reasonable market value should be over RMB20 billion. We recommend investors to follow closely with Sihuan, either for decent upside potential or privatization possibility.

Morning Views Asia: Powerlong Commercial Management Holdings, SJM Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma